FindTrial
Sign In

COMPARATIVE STUDY BETWEEN DEXMEDETOMIDINE VERSUS DEXAMETHASONE ALONG WITH 0.5% ROPIVACAINE IN ANAESTHEIC BLOCK GIVEN UNDER ULTRASOUND GUIDANCE AT SUPRACLAVICULAR AREA FOR UPPER LIMB SURGERIES

A COMPARATIVE STUDY BETWEEN DEXMEDETOMIDINE VERSUS DEXAMETHASONE AS ADJUVANT TO 0.5% ROPIVACAINE IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038117
Enrollment
62
Registered
2021-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I70-I79- Diseases of arteries, arterioles and capillaries Health Condition 2: S50-S59- Injuries to the elbow and forearm Health Condition 3: S60-S69- Injuries to the wrist, hand and fingers Health Condition 4: M259- Joint disorder, unspecified

Interventions

Intervention1: Supraclavicular brachial plexus block: Group- RD- 20mL of 0.5% Ropivacaine+Dexmedetomidine 1microg/kg diluted to total of 1mL Group RX- 20mL of 0.5% Ropivacaine + Dexamethasone 4mg Cont

Sponsors

Dr Anukrishna K V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Weight between 45 to 70Kgs, posted for elective and emergency surgeries below midarm, forearm and hand will be included

Exclusion criteria

Exclusion criteria: History of infection at site of block, history of coagulopathies, patients with known hypersensitivity to local anaesthetic or any study drug, patient with known hypersensitivity to local anaesthetic or any study drug, Patient with presence of 1st, 2nd or 3rd degree heart block, Pregnant women, Patient with pre-existing peripheral neuropathy

Design outcomes

Primary

MeasureTime frame
To assess the onset of sensory blockade and motor blockade, duration of sensory and motor blockade, duration of analgesiaTimepoint: 0,5, 10, 15, 20, 40, 60, 80, 100, 120, 140, 160 400, 640, 880, 1360, 1600 minutes—

Secondary

MeasureTime frame
To assess the total consumption of rescue analgesia in 24 hour postoperatively and to monitor hemodynamic stabilityTimepoint: 0,5, 10, 15, 20, 40, 60, 80, 100, 120, 140, 160 400, 640, 880, 1360, 1600 minutes—

Countries

India

Contacts

Public ContactANUKRISHNA K V

MGM Medical College and Hospital Aurangabad Maharashtra

pramod.bhale@gmail.com8888819021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026